"Although some of these substances may not be legally restricted in ordinary consumer contexts, we have proactively adopted stricter standards to define operational boundaries and our compliance efforts go beyond passive adherence and minimum legal requirements," the company said in a statement
Adults with CKD had a gain of 1.7 life-years free of new and recurrent CVD events
Peptide dosages can vary depending on your body composition, goals, and medical history
A 2022 JAMA study on 338 adults who had overweight or obesity found that taking semaglutide and liraglutide, respectively, led to an average 15.8% and 6.4% loss in body weight over 68 weeks
As clinical research progresses through 2026 and regulatory approval approaches, men on TRT considering retatrutide should maintain realistic expectations: this medication offers remarkable efficacy within the context of comprehensive lifestyle optimization, not as a replacement for fundamental metabolic health practices
Weight Loss Outcomes: What Happens Together